- Investing Ideas
- Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
7
Mid-Large Cap Stocks
7 companies
BioGaia
Market Cap: SEK 11.7b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 115.90
7D
2.6%
1Y
18.1%
Vitrolife
Market Cap: SEK 12.3b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 91.05
7D
0.1%
1Y
-34.4%
Camurus
Market Cap: SEK 37.2b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 624.50
7D
1.1%
1Y
-10.5%
AddLife
Market Cap: SEK 19.8b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 162.70
7D
1.1%
1Y
-5.7%
Bonesupport Holding
Market Cap: SEK 14.4b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 218.60
7D
-2.2%
1Y
-26.1%
BioArctic
Market Cap: SEK 29.8b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 335.60
7D
5.0%
1Y
39.1%
Swedish Orphan Biovitrum
Market Cap: SEK 159.8b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 460.00
7D
4.5%
1Y
58.3%